Skip to main content
Caplight Logo









AstronauTx

AstronauTx

Private
LondonHealthcare & Life Scienceshttps://astronautx.bio/

Last Round

Series A

Oct 9, 2023

Total Funding Raised

$70.17M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

AstronauTx is a biotechnology company that develops small-molecule therapeutics to treat Alzheimer's disease and other neurodegenerative disorders by correcting disrupted brain physiology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

small-molecule therapeuticsneurodegenerative diseaseAlzheimer's researchastrocyte dysfunctiondrug discoverybiotech startuppreclinical developmenttherapeutic pipelinedrug licensingbrain homeostasisneuroscience biotechtranslational biologyCNS drug discoverypharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AstronauTx Comparables

Compare AstronauTx with similar companies based on industry and business-model similarity.

AstronauTx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GliaPharm SA
86%
Muna Therapeutics
83%
Cellestial Health
81%

AstronauTx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 9, 2023
GrantSep 1, 2023
SeedMar 24, 2020
SeedAug 12, 2019

Key People

Founding team and executive leadership

Hannah Pearce

Chief Operating Officer

Executive Team

AstronauTx Investors

Notable investors and investment history

AstronauTx investors
InvestorRounds
Innovate UKGrant
MPM CapitalSeries A
EQT Life SciencesSeries A
UKRI Innovate UKGrant
MPM BioImpactSeries A
Albion CapitalSeed
Brandon CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 16, 2026

    Grew 18% QoQ, from 22 to 26 employees.

  • Jan 7, 2026

    Adam Rosenberg appointed as Chair of the Board of Directors.

Recent news

Latest coverage and updates

  • is_developingAug 10, 2026

    AstronauTx Ltd. is developing treatments for neurological conditions on Jul 1st '23.

  • is_developingAug 10, 2026

    AstronauTx Ltd. is developing therapeutic candidates on Aug 10th '26.

AstronauTx Filings

Explore SEC and related filing metadata, where available.

AstronauTx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AstronauTx's valuation, stock price, and market status.

Is AstronauTx a public or private company?

AstronauTx is a private company.

What is the current stock price of AstronauTx?

AstronauTx is a private company with no public stock price. No recent secondary market data is available.

How much is AstronauTx worth (valuation)?

Valuation information for AstronauTx is not publicly available.

Can I buy AstronauTx stock?

AstronauTx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AstronauTx's last funding round?

AstronauTx's most recent funding round was Series A on October 9, 2023.

Who are the main investors in AstronauTx?

Key investors in AstronauTx include Albion Capital.

Will AstronauTx IPO soon?

No public IPO plans have been announced for AstronauTx.

How can I track AstronauTx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AstronauTx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range17
Year Founded2019
Last FundingOct 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?